Cellerix, TiGenix deal

Musculoskeletal company TiGenix will acquire Cellerix in a stock deal that values Cellerix at €58 million ($79.8 million). TiGenix will issue 44.8 million new TiGenix shares at €1.30. Prior to the close of the deal, Cellerix will raise €18 million ($24.7 million) through an offering to existing investors, while TiGenix will raise about €15 million ($20.5 million) through the sale of 15 million shares at €1 in a rights issue. Former Cellerix investors will own 49% of the company with TiGenix investors owning the remaining 51%. ...